SBI Life Gets 'BUY' Upgrade on Growth, But Margin Pressure Lingers

INSURANCE
Whalesbook Logo
AuthorKavya Nair|Published at:
SBI Life Gets 'BUY' Upgrade on Growth, But Margin Pressure Lingers
Overview

Prabhudas Lilladher has upgraded SBI Life Insurance Company to a 'BUY' rating with a price target of INR 2,200, citing strong Annualised Premium Equivalent (APE) growth. Q4 FY26 saw APE rise 5% year-on-year, contributing to a 13% full-year growth. However, Value of New Business (VNB) margins contracted to 28.4% in Q4 and 27.5% for FY26, impacted by GST exemptions. Analysts project a gradual margin recovery to 27.6%-27.7% by FY27-FY28 as the GST impact neutralizes and the company diversifies away from ULIPs. Despite an overall positive outlook, the sustained margin pressure presents a key area for investor scrutiny.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

SBI Life Gains 'BUY' Rating on Strong Growth

Prabhudas Lilladher has upgraded SBI Life Insurance Company to a 'BUY' rating, setting a price target of INR 2,200. This upgrade comes despite challenges in Value of New Business (VNB) margins, driven by strong Annualised Premium Equivalent (APE) growth. The firm adjusted its valuation multiple to 2.0x from 2.5x, indicating a nuanced view that still favors the insurer's future prospects.

APE Growth Outpaces Margin Dip

SBI Life's performance in the fourth quarter of fiscal year 2026 saw APE increase by 5% year-on-year. This contributed to a robust 13% APE expansion for the full fiscal year, aligning with management's target of 14% growth. However, VNB margins narrowed to 28.4% in Q4 FY26 and 27.5% for the full year, mainly due to the impact of GST exemptions. For context, the company reported a solvency ratio of 196% a year prior.

Valuations, Sector Outlook, and Recovery Prospects

Analysts anticipate a gradual recovery in VNB margins to around 27.6%-27.7% by FY27-FY28. This recovery is expected as the GST exemption's effect diminishes and SBI Life further diversifies its product mix away from Unit Linked Insurance Plans (ULIPs). Current valuations show SBI Life trading at a higher Price-to-Earnings (P/E) ratio (TTM) of approximately 77.3x-81.8x compared to peers like HDFC Life (around 67.3x-69.9x) and ICICI Prudential Life (around 48.3x-49.5x). A MarketsMojo rating had previously adjusted to 'Hold' on February 2, 2026. The Indian life insurance sector, meanwhile, is forecast to grow at 8.35% annually through 2034, driven by demographics, rising incomes, and financial literacy.

Analyst Sentiment and Stock Performance

Despite the general analyst optimism, with 35 out of 36 analysts recommending 'Buy', concerns persist. Nomura maintained a 'Buy' rating but lowered its price target to INR 2,440 from INR 2,445 due to a slight miss on economic variance. The primary risk highlighted is the sustainability of VNB margin improvement, especially given the higher valuation. The stock closed down 1.39% on April 22, 2026, and has fallen approximately 16% over the past year.

Future Positioning in a Growing Market

Looking forward, SBI Life operates within a growing Indian life insurance market bolstered by favorable demographics and regulatory support like 100% foreign direct investment. Management's growth targets and analyst expectations for margin recovery form the basis of a positive outlook, positioning SBI Life to benefit from ongoing sector expansion.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.